Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Structural Basis of Spirolactone Recognition by the Mineralocorticoid Receptor

Jessica Huyet, Grégory M. Pinon, Michel R. Fay, Jérôme Fagart and Marie-Edith Rafestin-Oblin
Molecular Pharmacology September 2007, 72 (3) 563-571; DOI: https://doi.org/10.1124/mol.107.036459
Jessica Huyet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grégory M. Pinon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel R. Fay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jérôme Fagart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie-Edith Rafestin-Oblin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Spirolactones are potent antagonists of the mineralocorticoid receptor (MR), a ligand-induced transcription factor belonging to the nuclear receptor superfamily. Spirolactones are synthetic molecules characterized by the presence of a C17 γ-lactone, which is responsible for their antagonist character. They harbor various substituents at several positions of the steroid skeleton that modulate their potency in ways that remain to be determined. This is particularly obvious for C7 substituents. The instability of antagonist-MR complexes makes them difficult to crystallize. We took advantage of the S810L activating mutation in MR (MRS810L), which increases the stability of ligand-MR complexes to crystallize the ligand-binding domain (LBD) of MRS810L associated with 7α-acetylthio-17β-hydroxy-3-oxopregn-4-en-21-carboxylic acid γ-lactone (SC9420), a spirolactone with a C7 thioacetyl group. The crystal structure makes it possible to identify the contacts between SC9420 and MR and to elucidate the role of Met852 in the mode of accommodation of the C7 substituent of SC9420. The transactivation activities of MRS810L/Q776A, MRS810L/R817A, and MRS810L/N770A reveal that the contacts between SC9420 and the Gln776 and Arg817 residues are crucial to maintaining MRS810L in its active state, whereas the contact between SC9420 and the Asn770 residue contributes only to the high affinity of SC9420 for MR. Moreover, docking experiments with other C7-substituted spirolactones revealed that the MRS810L-activating potency of spirolactones is linked to the ability of their C7 substituent to be accommodated in LBD. It is remarkable that the MRS810L-activating and MRWT-inactivating potencies of the C7-substituted spirolactones follow the same order, suggesting that the C7 substituent is accommodated in the same way in MRS810L and MRWT. Thus, the MRS810L structure may provide a powerful tool for designing new, more effective, MR antagonists.

Footnotes

  • This work received funding from the Institut National de la Santé etdela Recherche Médicale (INSERM) and the European Symposium of the Aldosterone Council (ESAC).

  • The Protein Data Bank ID code for the structure of MRS810L-LBD associated with SC9420 is 2OAX.

  • Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.

  • doi:10.1124/mol.107.036459.

  • ABBREVIATIONS: SC9420, 7α-acetylthio-17β-hydroxy-3-oxopregn-4-en-21-carboxylic acid γ-lactone (spironolactone); RU26752, 7α-propyl-17β-hydroxy-3-oxopregn-4-en-21-carboxylic acid γ-lactone; LBD, ligand-binding domain; 18OVP, 18-oxo-18-vinylprogesterone; GST, glutathione transferase; PDB, Protein Data Bank; HEK, human embryonic kidney; MMTV, mouse mammary tumor virus; MR, mineralocorticoid receptor.

    • Received March 27, 2007.
    • Accepted June 12, 2007.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 72 (3)
Molecular Pharmacology
Vol. 72, Issue 3
1 Sep 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Structural Basis of Spirolactone Recognition by the Mineralocorticoid Receptor
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Structural Basis of Spirolactone Recognition by the Mineralocorticoid Receptor

Jessica Huyet, Grégory M. Pinon, Michel R. Fay, Jérôme Fagart and Marie-Edith Rafestin-Oblin
Molecular Pharmacology September 1, 2007, 72 (3) 563-571; DOI: https://doi.org/10.1124/mol.107.036459

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Structural Basis of Spirolactone Recognition by the Mineralocorticoid Receptor

Jessica Huyet, Grégory M. Pinon, Michel R. Fay, Jérôme Fagart and Marie-Edith Rafestin-Oblin
Molecular Pharmacology September 1, 2007, 72 (3) 563-571; DOI: https://doi.org/10.1124/mol.107.036459
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics